{"denoms":[{"counts":[{"groupId":"BG000","value":"91"},{"groupId":"BG001","value":"94"},{"groupId":"BG002","value":"185"}],"units":"Participants"}],"groups":[{"description":"Patients receive recombinant human papillomavirus nonavalent vaccine IM at baseline, 2 months, and 6 months.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nQuestionnaire Administration: Ancillary studies\n\nRecombinant Human Papillomavirus Nonavalent Vaccine: Given IM","id":"BG000","title":"Arm I (Recombinant Human Papillomavirus Nonavalent Vaccine)"},{"description":"Patients receive placebo IM at baseline, 2 months, and 6 months.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nPlacebo Administration: Given IM\n\nQuestionnaire Administration: Ancillary studies","id":"BG001","title":"Arm II (Placebo)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"47","upperLimit":"61","value":"53"},{"groupId":"BG001","lowerLimit":"51","upperLimit":"63","value":"57"},{"groupId":"BG002","lowerLimit":"48","upperLimit":"62","value":"55"}]}]}],"dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"99"}]}],"title":"Women"},{"categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"85"}]}],"title":"Men"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"Transgender women"}],"paramType":"NUMBER","title":"Sex/Gender, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"8"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"84"},{"groupId":"BG001","value":"89"},{"groupId":"BG002","value":"173"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"15"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"75"},{"groupId":"BG002","value":"145"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"12"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"7"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"91"},{"groupId":"BG001","value":"94"},{"groupId":"BG002","value":"185"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"50"},{"groupId":"BG001","value":"53"},{"groupId":"BG002","value":"103"}],"title":"Anal"},{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"41"},{"groupId":"BG002","value":"82"}],"title":"Vulvar"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Anatomic Site of HSIL (high-grade squamous intraepithelial lesion)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"40"},{"groupId":"BG001","value":"52"},{"groupId":"BG002","value":"92"}],"title":"Never"},{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"55"}],"title":"Former"},{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"38"}],"title":"Current"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Smoking Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"71"}],"title":"HIV Positive"},{"measurements":[{"groupId":"BG000","value":"59"},{"groupId":"BG001","value":"55"},{"groupId":"BG002","value":"114"}],"title":"HIV Negative"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"HIV Status","unitOfMeasure":"Participants"}],"populationDescription":"Participants who have completed Enrollment Visit and had at least 30 days follow-up after the initial dose of vaccine (n=185) were included in the intention-to-treat analysis and are considered part of the Baseline Analysis Population. Three participants (2 in Arm I/vaccine and 1 in Arm II/placebo) were excluded from analysis due to completing only one vaccination before study exit."}